We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

46 hedge funds and large institutions have $39.1M invested in Albireo Pharma Inc in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

601% more capital invested

Capital invested by funds: $5.58M → $39.1M (+$33.6M)

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

35% more funds holding

Funds holding: 34 → 46 (+12)

63% less call options, than puts

Call options by funds: $18K | Put options by funds: $48K

Holders
46
Holders Change
+12
Holders Change %
+35.29%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
14
Reduced
9
Closed
3
Calls
$18K
Puts
$48K
Net Calls
-$30K
Net Calls Change
-$25K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$6.77M
2
AIC
AWM Investment Company
New York
+$6.07M
3
BC
Broadfin Capital
New York
+$4.76M
4
GPP
Great Point Partners
Connecticut
+$4.49M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.48M

Top Sellers

Rank Fund Capital Flow
1
FMA
FNY Managed Accounts
New York
-$151K
2
Ameriprise
Ameriprise
Minnesota
-$117K
3
BBA
Baker Bros. Advisors
New York
-$36K
4
CC
Cannell & Co
New York
-$16K
5
Citadel Advisors
Citadel Advisors
Florida
-$14.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$30K -$638 -19 -2%
Nomura Holdings
27
Nomura Holdings
Japan
$28K +$30.2K +900 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$23K – – –
FAAS
29
First Allied Advisory Services
California
$21K – – –
RCM
30
Rotella Capital Management
Washington
$19K +$20.4K +607 New
Ameriprise
31
Ameriprise
Minnesota
$18K -$117K -3,487 -86%
ARTA
32
A.R.T. Advisors
New York
$18K -$6.58K -196 -24%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$15K +$4.17K +124 +35%
UBS Group
34
UBS Group
Switzerland
$13K +$11.8K +350 +449%
VKH
35
Virtu KCG Holdings
New York
$12K -$13.7K -408 -51%
BIM
36
BlackRock Investment Management
Delaware
$10K +$6.65K +198 +142%
BIT
37
BlackRock Institutional Trust
California
$10K +$11.2K +333 New
Citadel Advisors
38
Citadel Advisors
Florida
$7K -$14.4K -428 -65%
Wells Fargo
39
Wells Fargo
California
$5K +$5.61K +167 New
PMFA
40
Plante Moran Financial Advisors
Michigan
$2K – – –
Bank of America
41
Bank of America
North Carolina
$1K – – –
LTFS
42
Ladenburg Thalmann Financial Services
Florida
$1K – – –
BBA
43
Baker Bros. Advisors
New York
– -$36K -1,006 Closed
CC
44
Cannell & Co
New York
– -$16K -458 Closed
Creative Planning
45
Creative Planning
Kansas
– -$1K -22 Closed
Morgan Stanley
46
Morgan Stanley
New York
– +$302 +9 +900%
Citigroup
47
Citigroup
New York
– +$336 +10 New
1
2

ALBO Hedge Fund Activity: Q2 2015 in Review

46 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2015, worth a combined $39.1M — up 601% from $5.58M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ALBO positions and 3 closed out — a net gain of 12 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $6.77M. The largest seller was FNY Managed Accounts, cutting an estimated $151K.

  • 46 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2015, up from 34 in Q1 2015.
  • Funds reported $39.1M of Albireo Pharma Inc stock for Q2 2015, up 601% quarter-over-quarter.
  • 15 funds opened new Albireo Pharma Inc positions in Q2 2015 and 3 closed out, a net change of +12 holders.
  • The largest Albireo Pharma Inc buyer in Q2 2015 was Wellington Management Group, an estimated $6.77M added.
  • The largest Albireo Pharma Inc seller in Q2 2015 was FNY Managed Accounts, an estimated $151K sold.

Based on aggregated 13F filings for Q2 2015.